{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T16:50:15Z","timestamp":1761324615186,"version":"3.37.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,7]]},"DOI":"10.7759\/cureus.78720","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T07:10:01Z","timestamp":1738998601000},"source":"Crossref","is-referenced-by-count":2,"title":["Role of Echocardiography in Detecting Left Ventricular Dysfunction Among Diabetic Patients: A Clinical and Biochemical Perspective"],"prefix":"10.7759","author":[{"given":"Chandu","family":"Siripuram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Balu","family":"Mahendran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreelaxmi V","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjana","family":"Murali Krishna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shruti","family":"Suresh Suvarna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh","family":"Kandimalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun H","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, et al.. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022, 183:109119. 10.1016\/j.diabres.2021.109119","journal-title":"Diabetes Res Clin Pract"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v5.i4.444","article-title":"Type 2 diabetes and cardiovascular disease: have all risk factors the same strength?","volume":"5","author":"Mart\u00edn-Tim\u00f3n I","year":"2014","unstructured":"Mart\u00edn-Tim\u00f3n I, Sevillano-Collantes C, Segura-Galindo A, Del Ca\u00f1izo-G\u00f3mez FJ. Type 2 diabetes and cardiovascular disease: have all risk factors the same strength?. World J Diabetes. 2014, 5:444-70. 10.4239\/wjd.v5.i4.444","journal-title":"World J Diabetes"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/15.suppl_d.2","article-title":"Differentiation between systolic and diastolic dysfunction","volume":"15 Suppl D","author":"Federmann M","year":"1994","unstructured":"Federmann M, Hess OM. Differentiation between systolic and diastolic dysfunction. Eur Heart J. 1994, 15 Suppl D:2-6. 10.1093\/eurheartj\/15.suppl_d.2","journal-title":"Eur Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2018.10.038","article-title":"Left ventricular diastolic function: understanding pathophysiology, diagnosis, and prognosis\u00a0with\u00a0echocardiography","volume":"13","author":"Nagueh SF","year":"2020","unstructured":"Nagueh SF. Left ventricular diastolic function: understanding pathophysiology, diagnosis, and prognosis\u00a0with\u00a0echocardiography. JACC Cardiovasc Imaging. 2020, 13:228-44. 10.1016\/j.jcmg.2018.10.038","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/biom12040542","article-title":"Advanced glycation end products and diabetes mellitus: mechanisms and perspectives","volume":"12","author":"Khalid M","year":"2022","unstructured":"Khalid M, Petroianu G, Adem A. Advanced glycation end products and diabetes mellitus: mechanisms and perspectives. Biomolecules. 2022, 12:10.3390\/biom12040542","journal-title":"Biomolecules"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.hfc.2012.06.005","article-title":"Insulin resistance and heart failure: molecular mechanisms","volume":"8","author":"Aroor AR","year":"2012","unstructured":"Aroor AR, Mandavia CH, Sowers JR. Insulin resistance and heart failure: molecular mechanisms. Heart Fail Clin. 2012, 8:609-17. 10.1016\/j.hfc.2012.06.005","journal-title":"Heart Fail Clin"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.216","article-title":"Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy","volume":"12","author":"Jia G","year":"2016","unstructured":"Jia G, DeMarco VG, Sowers JR. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol. 2016, 12:144-53. 10.1038\/nrendo.2015.216","journal-title":"Nat Rev Endocrinol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.01.016","article-title":"Dynamics of diabetes and obesity: epidemiological perspective","volume":"1863","author":"Boles A","year":"2017","unstructured":"Boles A, Kandimalla R, Reddy PH. Dynamics of diabetes and obesity: epidemiological perspective. Biochim Biophys Acta Mol Basis Dis. 2017, 1863:1026-36. 10.1016\/j.bbadis.2017.01.016","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2016.08.018","article-title":"Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal","volume":"1863","author":"Kandimalla R","year":"2017","unstructured":"Kandimalla R, Thirumala V, Reddy PH. Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal. Biochim Biophys Acta Mol Basis Dis. 2017, 1863:1078-89. 10.1016\/j.bbadis.2016.08.018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2023.0036","article-title":"The role of echocardiography in evaluating cardiovascular diseases in patients with diabetes mellitus","volume":"47","author":"Lee SH","year":"2023","unstructured":"Lee SH, Park JH. The role of echocardiography in evaluating cardiovascular diseases in patients with diabetes mellitus. Diabetes Metab J. 2023, 47:470-83. 10.4093\/dmj.2023.0036","journal-title":"Diabetes Metab J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2579-0","article-title":"High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes","volume":"55","author":"Boonman-de Winter LJ","year":"2012","unstructured":"Boonman-de Winter LJ, Rutten FH, Cramer MJ, Landman MJ, Liem AH, Rutten GE, Hoes AW. High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes. Diabetologia. 2012, 55:2154-62. 10.1007\/s00125-012-2579-0","journal-title":"Diabetologia"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000146819.43235.A9","article-title":"Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials","volume":"110","author":"Young JB","year":"2004","unstructured":"Young JB, Dunlap ME, Pfeffer MA, et al.. Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials. Circulation. 2004, 110:2618-26. 10.1161\/01.CIR.0000146819.43235.A9","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2014.02.007","article-title":"The prevalence of diabetic cardiomyopathy: a population-based study in Olmsted County, Minnesota","volume":"20","author":"Dandamudi S","year":"2014","unstructured":"Dandamudi S, Slusser J, Mahoney DW, Redfield MM, Rodeheffer RJ, Chen HH. The prevalence of diabetic cardiomyopathy: a population-based study in Olmsted County, Minnesota. J Card Fail. 2014, 20:304-9. 10.1016\/j.cardfail.2014.02.007","journal-title":"J Card Fail"},{"key":"ref14","article-title":"Prevalence of diastolic dysfunction in type 2 diabetes mellitus","volume":"15","author":"Yadava SK","year":"2017","unstructured":"Yadava SK, Dolma N, Lamichhane G, Poudel N, Barakoti M, Karki DB. Prevalence of diastolic dysfunction in type 2 diabetes mellitus. Kathmandu Univ Med J. 2017, 15:212-6.","journal-title":"Kathmandu Univ Med J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2015\/13348.6376","article-title":"Study on diastolic dysfunction in newly diagnosed type 2 diabetes mellitus and its correlation with glycosylated haemoglobin (HbA1C)","volume":"9","author":"Chaudhary AK","year":"2015","unstructured":"Chaudhary AK, Aneja GK, Shukla S, Razi SM. Study on diastolic dysfunction in newly diagnosed type 2 diabetes mellitus and its correlation with glycosylated haemoglobin (HbA1C). J Clin Diagn Res. 2015, 9:OC20-2. 10.7860\/JCDR\/2015\/13348.6376","journal-title":"J Clin Diagn Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.241.19.2035","article-title":"Diabetes and cardiovascular disease. The Framingham study","volume":"241","author":"Kannel WB","year":"1979","unstructured":"Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979, 241:2035-8. 10.1001\/jama.241.19.2035","journal-title":"JAMA"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyr120","article-title":"China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up","volume":"40","author":"Chen Z","year":"2011","unstructured":"Chen Z, Chen J, Collins R, Guo Y, Peto R, Wu F, Li L. China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol. 2011, 40:1652-66. 10.1093\/ije\/dyr120","journal-title":"Int J Epidemiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096808","article-title":"Prevalence of dyslipidemia in urban and rural India: the ICMR-INDIAB study","volume":"9","author":"Joshi SR","year":"2014","unstructured":"Joshi SR, Anjana RM, Deepa M, et al.. Prevalence of dyslipidemia in urban and rural India: the ICMR-INDIAB study. PLoS One. 2014, 9:e96808. 10.1371\/journal.pone.0096808","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2291-5","article-title":"Prevalence of diabetes and prediabetes (impaired fasting glucose and\/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study","volume":"54","author":"Anjana RM","year":"2011","unstructured":"Anjana RM, Pradeepa R, Deepa M, et al.. Prevalence of diabetes and prediabetes (impaired fasting glucose and\/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia. 2011, 54:3022-7. 10.1007\/s00125-011-2291-5","journal-title":"Diabetologia"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf S","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, et al.. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004, 364:937-52. 10.1016\/S0140-6736(04)17018-9","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32008-2","article-title":"Modifiable risk factors, cardiovascular disease, and mortality in 155\u2008722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study","volume":"395","author":"Yusuf S","year":"2020","unstructured":"Yusuf S, Joseph P, Rangarajan S, et al.. Modifiable risk factors, cardiovascular disease, and mortality in 155\u2008722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020, 395:795-808. 10.1016\/S0140-6736(19)32008-2","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","unstructured":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998, 352.837-53. 10.1016\/S0140-6736(98)07019-6","journal-title":"Lancet"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.31626","article-title":"Association of glycosylated haemoglobin (HbA1c) level with left ventricular diastolic dysfunction in patients with type 2 diabetes","volume":"14","author":"Guria RT","year":"2022","unstructured":"Guria RT, Prasad MK, Mishra B, Marandi S, Kumar A, Dungdung A. Association of glycosylated haemoglobin (HbA1c) level with left ventricular diastolic dysfunction in patients with type 2 diabetes. Cureus. 2022, 14:e31626. 10.7759\/cureus.31626","journal-title":"Cureus"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker PM","year":"2008","unstructured":"Ridker PM, Danielson E, Fonseca FA, et al.. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008, 359:2195-207. 10.1056\/NEJMoa0807646","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker PM","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, et al.. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017, 377:1119-31. 10.1056\/NEJMoa1707914","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2014.11.005","article-title":"C-reactive protein, inflammation and coronary heart disease","volume":"67","author":"Shrivastava AK","year":"2015","unstructured":"Shrivastava AK, Singh HV, Raizada A, Singh SK. C-reactive protein, inflammation and coronary heart disease. Egypt Heart J. 2015, 67:89-97. 10.1016\/j.ehj.2014.11.005","journal-title":"Egypt Heart J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2012.05.015","article-title":"Serum high sensitivity C-reactive protein, nitric oxide metabolites, plasma fibrinogen, and lipid parameters in Indian type 2 diabetic males","volume":"6","author":"Sarangi R","year":"2012","unstructured":"Sarangi R, Padhi S, Mohapatra S, et al.. Serum high sensitivity C-reactive protein, nitric oxide metabolites, plasma fibrinogen, and lipid parameters in Indian type 2 diabetic males. Diabetes Metab Syndr. 2012, 6:9-14. 10.1016\/j.dsx.2012.05.015","journal-title":"Diabetes Metab Syndr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/332413-role-of-echocardiography-in-detecting-left-ventricular-dysfunction-among-diabetic-patients-a-clinical-and-biochemical-perspective","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T07:10:03Z","timestamp":1738998603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/332413-role-of-echocardiography-in-detecting-left-ventricular-dysfunction-among-diabetic-patients-a-clinical-and-biochemical-perspective"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.78720","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,7]]}}}